Fenway Institute Report: PrEP could be “game changer” in fight against HIV
Analysis examines biomedical prevention technology to be reviewed by U.S. Food and Drug Administration by June 15, 2012 BOSTON, Mass. — Pre-exposure chemoprophylaxis (PrEP)—taking antiretroviral…